Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome

Urology

Volumn 83, Issue 1, 2014, Pages 167-174

  Francomano, Davide ^a   Ilacqua, Alessandro ^a   Bruzziches, Roberto ^a   Lenzi, Andrea ^a   Aversa, Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG SAFETY; ECHOGRAPH; HEALTH IMPACT ASSESSMENT; HEMATOCRIT; HUMAN; HYPOGONADISM; INTERNATIONAL PROSTATE SYMPTOM SCORE; LONG TERM CARE; LOWER URINARY TRACT SYMPTOM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORBIDITY; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; POPULATION RESEARCH; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE SIZE; PROSTATE VOLUME; PROSTATITIS; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; URINARY TRACT FUNCTION; URINE FLOW RATE;

AGED; ANDROGENS; HUMANS; HYPOGONADISM; LOWER URINARY TRACT SYMPTOMS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; TESTOSTERONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891278296     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.08.019     Document Type: Article

References (30)

1. C. Robertson, C.L. Link, and E. Onel et al. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies BJU Int 99 2007 347 354
2. G. Schatzl, S. Madersbacher, and C. Temml et al. Serum androgen levels in men: impact of health status and age Urology 61 2003 629 633
3. S.J. Berry, D.S. Coffey, P.C. Walsh, and L.L. Ewing The development of human benign prostatic hyperplasia with age J Urol 132 1984 474 479
4. J.S. Paick, J.H. Yang, and S.W. Kim et al. Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study Asian J Androl 9 2007 213 220
5. K.G. Alberti, P. Zimmet, J. Shaw IDF Epidemiology Task Force Consensus Group The metabolic syndrome-a new worldwide definition Lancet 366 2005 1059 1062
6. K.E. el Din, W.F. Koch, and M.J. de Wildt et al. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia J Urol 155 1996 1959 1964
7. L.S. Marks, N.A. Mazer, and E. Mostaghel et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial JAMA 296 2006 2351 2361
8. E.S. Chenven, D.B. Glazier, and E.B. Krisch et al. Evaluation of prostate volume by transrectal ultrasonography for use in a brachytherapy program Urology 58 2001 752 755
9. S.A. Kaplan, C.G. Roehrborn, and J.D. McConnell et al. Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial J Urol 180 2008 1030 1032 [discussion: 1032-1033]
10. Grabe M, Bjerklund-Johansen TE, Botto H, et al. European Association of Urology. Guidelines on urological infections. Available at: http://www.uroweb. org/gls/pockets/english/17%20Urological%20Infections-LR.pdf. Accessed August 1, 2013.
11. H.J. Litman, S. Bhasin, and M.P. O'Leary et al. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey BJU Int 100 2007 321 326
12. S. Rohrmann, W.G. Nelson, and N. Rifai et al. Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III) Urology 69 2007 708 713
13. M.D. Trifiro, J.K. Parsons, and K. Palazzi-Churas et al. Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men BJU Int 105 2010 1554 1559
14. M.O. Tan, I. Karabiyik, and M.C. Uygur et al. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia Int Urol Nephrol 35 2003 357 363
15. G. Schatzl, C. Brössner, and S. Schmid et al. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology Urology 55 2000 397 402
16. A. Aversa, R. Bruzziches, and D. Francomano et al. Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome J Endocrinol Invest 33 2010 776 783
17. A. Aversa, R. Bruzziches, and D. Francomano et al. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study J Sex Med 7 2010 3495 3503
18. A. Aversa, R. Bruzziches, and D. Francomano et al. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study Aging Male 15 2012 96 102
19. A.A. Yassin, Al El-Sakka, and F. Saad et al. Lower urinary-tract symptoms and testosterone in elderly men World J Urol 26 2008 359 364
20. A.K. Chavalmane, P. Comeglio, and A. Morelli et al. Sex steroid receptors in male human bladder: expression and biological function J Sex Med 8 2010 2698 2713
21. T.W. Watkins, and J.R. Keast Androgen-sensitive preganglionic neurons innervate the male rat pelvic ganglion Neuroscience 93 1999 1147 1157
22. Y.S. Juan, B. Onal, and S. Broadaway et al. Effect of castration on male rabbit lower urinary tract tissue enzymes Mol Cell Biochem 301 2007 227 233
23. L. Vignozzi, A. Morelli, and E. Sarchielli et al. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit J Endocrinol 212 2012 71 84
24. L. Vignozzi, S. Filippi, and A. Morelli et al. Testosterone/estradiol ratio regulates no-induced bladder relaxation and responsiveness to PDE5 inhibitors J Sex Med 9 2012 3028 3040
25. B. Fibbi, G. Penna, and A. Morelli et al. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia Int J Androl 33 2010 475 488
26. J.S. Tenover Effects of testosterone supplementation in the aging male J Clin Endocrinol Metab 75 1992 1092 1098
27. F. Franchi, M. Luisi, and P.M. Kicovic Long-term study of oral testosterone undecanoate in hypogonadal males Int J Androl 1 1978 270 278
28. H.M. Behre, J. Bohmeyer, and E. Nieschlag Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls Clin Endocrinol (Oxf) 40 1994 341 349
29. T. Takao, A. Tsujimura, and J. Nakayama et al. Lower urinary tract symptoms after hormone replacement therapy in Japanese patients with late-onset hypogonadism: a preliminary report Int J Urol 16 2009 212 214
30. L.J. Gooren A ten-year safety study of the oral androgen testosterone undecanoate J Androl 15 1994 212 215